Montefiore-Einstein Heart Center
Department of Cardiothoracic Surgery
invites you to attend
Success with Heart Failure
Perspectives from the Big Apple
A day of insight & innovation with international experts in the treatment of heart failure.
June 20, 2008
7:00am - 4:30pm
Harvard Club, New York City
Intended Audience
This activity is designed for physicians, nurses, perfusionists, transplant coordinators and allied healthcare professionals.
Statement of Need
Over 500,000 new cases of congestive heart failure are diagnosed in the United States each year. Medical and surgical therapies for heart failure are continuously evolving and offer many options to extend and improve life for patients. This meeting will review recent findings and present new information on medical therapies, conventional surgery, ventricular reconstruction, mechanical circulatory support, and cellular cardiomyoplasty.
Learning Objectives
After participating in this program, the participants should be able to:
Itinerary
| 7:00 - 7:50 am | Breakfast/Registration (Harvard Hall) | |
| 7:50 - 8:00 | Welcome Address Robert Michler, MD |
|
| The Changing Face of Heart Failure | ||
| 8:00 - 8:30 | Current Controversies in Statin Therapy James B. Young, MD Cleveland Clinic / Case Western Reserve University |
|
| 8:30 - 9:00 | LV Recovery – What is the Likelihood of a Lasting Benefit? Simon Maybaum, MD Montefiore Medical Center / Albert Einstein College of Medicine |
|
| 9:00 - 9:30 | Resynchronization Therapy – Failure to Improve After CRT Andrew Krumerman, MD Montefiore Medical Center / Albert Einstein College of Medicine |
|
| 9:30 - 9:45 | Q&A | |
| 9:45 - 10:00 | Break | |
| Surgical Therapies for Heart Failure | ||
| 10:00 - 10:30 | The STICH Trial: Concept and Implications Robert Michler, MD Montefiore Medical Center / Albert Einstein College of Medicine |
|
| 10:30 - 11:00 | When is LV Dysfunction a Contraindication to MV Repair or Replacement? Vivek Rao, MD, PhD University of Toronto / Toronto General Hospital |
|
| 11:00 - 11:30 | Atrial Fibrillation – Lesion Sets and Measuring Outcomes A. Marc Gillinov, MD Cleveland Clinic |
|
| 11:30 - 11:45 | Q&A | |
| 11:45 - 1:00 pm | LUNCH (Biddle Room 2nd Floor) | |
| Lari Attai Lecture | ||
| 1:00 - 1:20 pm | Stories for the Heart: Medicine, Media and the Public Bernadine Healy, MD |
|
| 1:20 - 1:45 | Q&A | |
| 1:45 - 2:00 | Break | |
| Myocardial Regeneration and Mechanical Devices | ||
| 2:00 - 2:30 | Expectations for Cell Therapy – Reasonable & Unreasonable Marc Penn, MD, PhD Cleveland Clinic |
|
| 2:30 - 3:00 | INTERMACS Registry – Relationship to Device Development and the FDA Robert Kormos, MD University of Pittsburgh |
|
| 3:00 - 3:30 | HeartMate II – Implications of FDA Approval Leslie Miller, MD Washington Hospital Center / Georgetown University Hospital |
|
| 3:30 - 4:00 | Novel Early-Clinical Mechanical Devices Daniel Goldstein, MD Montefiore Medical Center / Albert Einstein College of Medicine |
|
| 4:00 - 4:15 | Q&A | |
| 4:15 - 4:30 | Closing Remarks | |
© 2008 Montefiore Medical Center